Synthesis, Computational Studies, Antioxidant and Anti-Inflammatory Bio-Evaluation of 2,5-Disubstituted-1,3,4-Oxadiazole Derivatives

The 1,3,4-oxadiazole derivatives Ox-6a-f have been synthesized by incorporating flurbiprofen moiety with the aim to explore the potential of target molecules to decrease the oxidative stress. The title compounds Ox-6a-f were prepared by simple reactions in which a flurbiprofen –COOH group was esterified with methanol in an acid-catalyzed medium, which was then reacted with hydrazine to afford the corresponding hydrazide. The acid hydrazide was then cyclized into 1,3,4-oxadiazole-2-thiol by reacting with CS2 in the presence of KOH. The title compounds Ox-6a-f were synthesized by the reaction of an –SH group with various alkyl/aryl chlorides, which involves an S-alkylation reaction. The structures of the synthesized Ox-6a-f derivatives were ascertained by spectroscopic data. The in silico molecular docking was performed against target proteins cyclooxygenase-2 COX-2 (PDBID 5KIR) and cyclooxygenase-1 COX-1 (PDBID 6Y3C) to determine the binding affinity of the synthesized compounds with these structures. It has been inferred that most of the synthesized compounds bind well with an active binding site of 5KIR compared to 6Y3C, and especially compound Ox-6f showed excellent binding affinity (7.70 kcal/mol) among all synthesized compounds Ox-6a-f. The molecular dynamic (MD) simulation has also been performed to check the stability of docking complexes of ligands with COX-2 by determining their root mean square deviation and root mean square fluctuation. Little fluctuation was observed in case of Ox-6f, which forms the most stable complex with COX-2. The comprehensive antioxidant potential of the synthesized compounds has been evaluated by determining their free radical scavenging activity, including DPPH, OH, nitric oxide (NO), and iron chelation assay. The derivative Ox-6f showed promising results with 80.23% radical scavenging potential at a dose of 100 µg/mL while ascorbic acid exhibited 87.72% inhibition at the same dose. The anti-inflammatory activity of the final products has also been performed, and inflammatory markers were assayed, such as a thiobarbituric acid-reducing substance, nitric oxide, interleukin-6 (IL-6), and COX-2. The derivatives Ox-6d and Ox-6f displayed higher anti-inflammatory activity, exhibiting 70.56% and 74.16% activity, respectively. The results were compared with standard ibuprofen, which showed 84.31% activity at the same dose, 200 µg/mL. The anti-inflammatory potential has been performed by following the carrageen-induced hind paw edema model, and results showed that derivative Ox-6f exhibited 79.83% reduction in edema volume compared to standard ibuprofen, which reduced 84.31% edema volume. As dry lab and wet lab results confirm each other, it has been deduced that derivative Ox-6f may serve as the lead structure to design potent compounds to address oxidative stress.

[1]  P. Osyczka,et al.  Membrane lipid peroxidation in lichens determined by the TBARS assay as a suitable biomarker for the prediction of elevated level of potentially toxic trace elements in soil , 2023, Ecological Indicators.

[2]  Aiguo Zhong,et al.  Copper-catalyzed asymmetric 1,6-conjugate addition of in situ generated para-quinone methides with β-ketoesters. , 2022, Chemical communications.

[3]  A. Kudelko,et al.  Synthesis and Biological Activity of 1,3,4-Oxadiazoles Used in Medicine and Agriculture , 2022, Applied Sciences.

[4]  Mubashir Hassan,et al.  Stress Driven Discovery of Natural Products From Actinobacteria with Anti-Oxidant and Cytotoxic Activities Including Docking and ADMET Properties , 2021, International journal of molecular sciences.

[5]  Jianguo Yang,et al.  Chemoselective hydroborative reduction of nitro motifs using a transition-metal-free catalyst , 2021, Organic Chemistry Frontiers.

[6]  Aiguo Zhong,et al.  Transition-metal-free catalytic hydroboration reduction of amides to amines , 2020, Organic Chemistry Frontiers.

[7]  Jianguo Yang,et al.  Combined KOH/BEt3 Catalyst for Selective Deaminative Hydroboration of Aromatic Carboxamides for Construction of Luminophores. , 2020, Organic letters.

[8]  Xiaopeng Song,et al.  Aminoguanidine inhibits IL-1β-induced protein expression of iNOS and COX-2 by blocking the NF-κB signaling pathway in rat articular chondrocytes , 2020, Experimental and therapeutic medicine.

[9]  I. Haq,et al.  Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia , 2020, BMC Complementary Medicine and Therapies.

[10]  Z. Iqbal,et al.  Sulfonamide-Based Azaheterocyclic Schiff Base Derivatives as Potential Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxicity, and Enzyme Inhibitory Kinetics , 2020, BioMed research international.

[11]  Deman Han,et al.  Sodium Triethylborohydride-Catalyzed Controlled Reduction of Unactivated Amides to Secondary or Tertiary Amines. , 2019, The Journal of organic chemistry.

[12]  J. Zhao,et al.  Anti-inflammatory effect and potential mechanism of betulinic acid on λ-carrageenan-induced paw edema in mice. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Z. Iqbal,et al.  Substituted phenyl[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetates/acetamides as alkaline phosphatase inhibitors: Synthesis, computational studies, enzyme inhibitory kinetics and DNA binding studies. , 2019, Bioorganic chemistry.

[14]  Z. Iqbal,et al.  Synthesis and docking studies of N‐(5‐(alkylthio)‐1,3,4‐oxadiazol‐2‐yl)methyl)benzamide analogues as potential alkaline phosphatase inhibitors , 2019, Drug development research.

[15]  M. H. Hadwan,et al.  Simple spectrophotometric assay for measuring catalase activity in biological tissues , 2018, BMC Biochemistry.

[16]  Mohammad Sarwar Alam,et al.  Synthesis of benzimidazole-linked-1,3,4-oxadiazole carboxamides as GSK-3β inhibitors with in vivo antidepressant activity. , 2018, Bioorganic chemistry.

[17]  M. Akhtar,et al.  Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents. , 2018, Bioorganic chemistry.

[18]  K. Ayub,et al.  Synthesis, crystal structures, computational studies and antimicrobial activity of new designed bis((5-aryl-1,3,4-oxadiazol-2-yl)thio)alkanes , 2018 .

[19]  A. A. Siddiqui,et al.  Exploring 1,3,4-Oxadiazole Scaffold for Anti-inflammatory and Analgesic Activities: A Review of Literature From 2005-2016. , 2018, Mini reviews in medicinal chemistry.

[20]  T. Kaoud,et al.  New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability. , 2017, Bioorganic chemistry.

[21]  M. Pattarawarapan,et al.  Application of N-Acylbenzotriazoles in the Synthesis of 5-Substituted 2-Ethoxy-1,3,4-oxadiazoles as Building Blocks toward 3,5-Disubstituted 1,3,4-Oxadiazol-2(3H)-ones. , 2017, The Journal of organic chemistry.

[22]  Muhammad Rashid Khan,et al.  Euphorbia dracunculoides L. abrogates carbon tetrachloride induced liver and DNA damage in rats , 2017, BMC Complementary and Alternative Medicine.

[23]  Kazuyuki Tokumaru,et al.  A convergent synthesis of 1,3,4-oxadiazoles from acyl hydrazides under semiaqueous conditions† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc00195a Click here for additional data file. , 2017, Chemical science.

[24]  A. Kudelko,et al.  Oxidative cyclization of N-aroylhydrazones to 2-(2-arylethenyl)-1,3,4-oxadiazoles using DDQ as an efficient oxidant , 2015 .

[25]  Mehr-un-Nisa,et al.  Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors. , 2015, Bioorganic & medicinal chemistry.

[26]  N. Ismail,et al.  Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies. , 2015, Bioorganic & medicinal chemistry.

[27]  A. Hemmati,et al.  A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats , 2015, Indian journal of pharmacology.

[28]  M. El-Gamal,et al.  Synthesis and in vitro antiproliferative activity of new 1,3,4-oxadiazole derivatives possessing sulfonamide moiety. , 2015, European journal of medicinal chemistry.

[29]  Haitian Ma,et al.  Synthesis and antioxidant activity of novel Mannich base of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan. , 2013, Bioorganic & medicinal chemistry.

[30]  Peter M. Kasson,et al.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..

[31]  C. Senanayake,et al.  A highly convergent and efficient synthesis of a macrocyclic hepatitis C virus protease inhibitor BI 201302. , 2013, Organic letters.

[32]  M. Hanif,et al.  Synthesis, Acetylcholinesterase and Alkaline Phosphatase Inhibition of Some New 1,2,4-Triazole and 1,3,4-Thiadiazole Derivatives , 2012 .

[33]  R. Prakash,et al.  Review of oxidative stress in relevance to uremia , 2012 .

[34]  David W. Johnson,et al.  Oxidative stress, anti‐oxidant therapies and chronic kidney disease , 2012, Nephrology.

[35]  Jiang He,et al.  Inhibition of tobacco bacterial wilt with sulfone derivatives containing an 1,3,4-oxadiazole moiety. , 2012, Journal of agricultural and food chemistry.

[36]  B. Kalluraya,et al.  Synthesis and biological property of some novel 1,3,4-oxadiazoles. , 2010, European journal of medicinal chemistry.

[37]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[38]  A. Sontakke,et al.  Oxidative stress in Parkinson’s disease , 2009, Indian Journal of Clinical Biochemistry.

[39]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[40]  M. Poirier,et al.  A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors. , 2004, Journal of medicinal chemistry.

[41]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[42]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[43]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[44]  David S. Wishart,et al.  VADAR: a web server for quantitative evaluation of protein structure quality , 2003, Nucleic Acids Res..

[45]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[46]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[47]  Lelyukh Maryan,et al.  Approaches for synthesis and chemical modification of non-condensed heterocyclic systems based on 1,3,4-oxadiazole ring and their biological activity: A review , 2020 .

[48]  Arthur J Olson,et al.  Small-molecule library screening by docking with PyRx. , 2015, Methods in molecular biology.

[49]  Elizabeth Duffy,et al.  Detection and quantification of cytokines and other biomarkers. , 2012, Methods in molecular biology.

[50]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[51]  A. Boveris,et al.  Antioxidant and Prooxidant Activities in Aqueous Extracts of Argentine Plants , 1997 .